Literature DB >> 10326169

Weight gain and insulin resistance during nicotine replacement therapy.

A R Assali1, Y Beigel, R Schreibman, Z Shafer, M Fainaru.   

Abstract

BACKGROUND: Although the cessation of smoking reduces the increased risk for ischemic heart disease, it is associated with marked weight gain and presumably insulin resistance, both of which heighten the risk of coronary heart disease. HYPOTHESIS: We investigated the isolated effect of nicotine on body weight and insulin resistance during smoking cessation.
METHODS: Eleven healthy, middle-aged heavy smokers were studied. Insulin sensitivity was assessed by an insulin-enhanced, frequently sampled intravenous glucose tolerance test with minimal model analysis. The subjects were studied at baseline (last day of smoking) (phase 1), at the end of the 6-week nicotine replacement program (phase 2), and after 8 weeks without smoking or nicotine replacement (phase 3).
RESULTS: The subjects started to gain weight during nicotine replacement (phase 2) (0.3 +/- 0.2 kg/week, mean +/- standard deviation) and continued to do so at a steady rate after nicotine replacement was stopped (0.2 +/- 0.2 kg/week) (p = 0.3). Insulin sensitivity decreased by 14 +/- 2.6% during nicotine replacement but increased by 16 +/- 5.1% (compared with phase 2) during phase 3, even though the weight gain continued (p = 0.047; 95% confidence interval: 0.05-5.73).
CONCLUSIONS: Smoking cessation is associated with weight gain and improvement in insulin resistance. Nicotine is the main ingredient in cigarette smoke causing insulin resistance, but the withdrawal of another, unknown ingredient in cigarette smoke is responsible for the weight gain associated with smoking cessation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10326169      PMCID: PMC6656158          DOI: 10.1002/clc.4960220512

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  11 in total

Review 1.  Metabolic effects of smoking cessation.

Authors:  Kindred K Harris; Mohan Zopey; Theodore C Friedman
Journal:  Nat Rev Endocrinol       Date:  2016-03-04       Impact factor: 43.330

Review 2.  Effects of nicotine on homeostatic and hedonic components of food intake.

Authors:  Andrea Stojakovic; Enma P Espinosa; Osman T Farhad; Kabirullah Lutfy
Journal:  J Endocrinol       Date:  2017-10       Impact factor: 4.286

3.  The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.

Authors:  Amanda K Woynillowicz; Sandeep Raha; Catherine J Nicholson; Alison C Holloway
Journal:  Toxicol Appl Pharmacol       Date:  2012-08-27       Impact factor: 4.219

4.  Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR inhaled insulin pharmacokinetics and glucodynamics.

Authors:  Alan X Pan; Amparo de la Peña; Kwee P Yeo; Clark Chan; Mei T Loh; Stephen D Wise; Bernard L Silverman; Douglas B Muchmore
Journal:  Br J Clin Pharmacol       Date:  2007-10-08       Impact factor: 4.335

5.  Effects of isolated tobacco alkaloids and tobacco products on deprivation-induced food intake and meal patterns in rats.

Authors:  Patricia E Bunney; Mylissa Hansen; Mark LeSage
Journal:  Pharmacol Biochem Behav       Date:  2017-11-28       Impact factor: 3.533

Review 6.  Cardiometabolic Morbidity and Mortality with Smoking Cessation, Review of Recommendations for People with Diabetes and Obesity.

Authors:  Katarina Kos
Journal:  Curr Diab Rep       Date:  2020-12-08       Impact factor: 4.810

7.  Metabolic parameters in smokers undergoing smoking reduction.

Authors:  Stanley H Hsia; Monica L Nisis; Martin L Lee; Candice Goldstein; Theodore C Friedman
Journal:  J Clin Transl Endocrinol       Date:  2021-01-23

8.  Chronic exposure to nicotine enhances insulin sensitivity through α7 nicotinic acetylcholine receptor-STAT3 pathway.

Authors:  Tian-Ying Xu; Ling-Ling Guo; Pei Wang; Jie Song; Ying-Ying Le; Benoit Viollet; Chao-Yu Miao
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

9.  Exploratory survey study of long-term users of nicotine replacement therapy in Danish consumers.

Authors:  Gitte Borup; Kim Lyngby Mikkelsen; Philip Tønnesen; Lona Louring Christrup
Journal:  Harm Reduct J       Date:  2015-01-19

10.  Smoking-by-genotype interaction in type 2 diabetes risk and fasting glucose.

Authors:  Peitao Wu; Denis Rybin; Lawrence F Bielak; Mary F Feitosa; Nora Franceschini; Yize Li; Yingchang Lu; Jonathan Marten; Solomon K Musani; Raymond Noordam; Sridharan Raghavan; Lynda M Rose; Karen Schwander; Albert V Smith; Salman M Tajuddin; Dina Vojinovic; Najaf Amin; Donna K Arnett; Erwin P Bottinger; Ayse Demirkan; Jose C Florez; Mohsen Ghanbari; Tamara B Harris; Lenore J Launer; Jingmin Liu; Jun Liu; Dennis O Mook-Kanamori; Alison D Murray; Mike A Nalls; Patricia A Peyser; André G Uitterlinden; Trudy Voortman; Claude Bouchard; Daniel Chasman; Adolfo Correa; Renée de Mutsert; Michele K Evans; Vilmundur Gudnason; Caroline Hayward; Linda Kao; Sharon L R Kardia; Charles Kooperberg; Ruth J F Loos; Michael M Province; Tuomo Rankinen; Susan Redline; Paul M Ridker; Jerome I Rotter; David Siscovick; Blair H Smith; Cornelia van Duijn; Alan B Zonderman; D C Rao; James G Wilson; Josée Dupuis; James B Meigs; Ching-Ti Liu; Jason L Vassy
Journal:  PLoS One       Date:  2020-05-07       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.